For enterprise medtech leaders ready to operationalize AI
Unlocking Potential with AI‑Driven Growth
Savi Advisors AI Health partners with medical device enterprises to design and execute AI strategies that move the needle on revenue, market access, and commercial efficiency—without disrupting regulatory rigor or clinical trust.
Sarah Thompson, Marketing Director at a leading med-device company, used Savi’s AI Growth Blueprint to re-focus spend, sharpen positioning, and surface new revenue opportunities in under 90 days.
A 30-minute working session to identify 2–3 AI growth levers tailored to your portfolio and markets.
- Built for enterprise medtech: portfolios spanning devices, diagnostics, and digital
- Fluent in regulatory, clinical, and commercial constraints
- Independent, data-driven guidance—not another generic AI pitch
AI Health Growth Snapshot
See how peers are reallocating budgets, prioritizing AI initiatives, and structuring pilots to prove commercial impact before scale.
What you’ll receive in your session
• A concise AI growth diagnostic
• Prioritized opportunities across marketing, sales, and market access
• Clear next steps for your team—whether or not we work together
Tailored AI Solutions
Built specifically for enterprise medical device organizations, our advisory work bridges AI innovation with disciplined, measurable commercial outcomes.
AI‑Ready Commercial Strategy
Align AI investments with portfolio, indications, and geography. We quantify where AI can de-risk launches, expand indications, and optimize channel mix across your markets.
- Commercial use‑case discovery and sizing
- Evidence-led opportunity prioritization
- Roadmaps aligned with regulatory and market access timelines
AI‑Enabled Marketing & Segmentation
Use AI responsibly to sharpen targeting and messaging across clinical decision-makers, administrators, and procurement—without compromising compliance or trust.
- Predictive account and territory scoring
- Persona and pathway‑based messaging frameworks
- AI‑assisted content testing and optimization
AI Operating Models & Governance
Design cross‑functional ways of working so marketing, medical, legal, and data teams can move at speed while managing risk and data stewardship.
- AI steering and governance frameworks
- Risk, compliance, and audit considerations
- Capability building for marketing and commercial teams
A Strategic Growth Framework for Medtech AI
Our framework gives leaders like Sarah Thompson a structured, defensible way to move from AI curiosity to measurable commercial value—without betting the entire portfolio on unproven ideas.
Each phase is designed to create clarity for executives, actionable direction for teams, and traceable evidence for compliance and regulatory stakeholders.
The Savi AI Growth Framework
- 1. Discover — Audit data, channels, and in‑market performance to identify credible AI use cases tied to revenue and efficiency.
- 2. Prioritize — Score opportunities across value, feasibility, risk, and time to impact; build an executive‑ready AI growth thesis.
- 3. Design — Translate priority opportunities into clear pilots, success metrics, and operating requirements across teams.
- 4. Prove — Run controlled pilots with robust measurement plans and governance to build trust and secure scale‑up approval.
- 5. Scale — Embed successful AI capabilities into processes, playbooks, and platforms across regions and business units.
Client Transformation
How a global med‑device marketing director used Savi to turn scattered AI experiments into a focused, defensible growth program.
"We had pilots everywhere—chatbots here, predictive scoring there—but no coherent AI story. Savi helped us step back, quantify impact, and concentrate on the few initiatives that would actually reshape growth."
Sarah Thompson
Marketing Director, Global Med‑Device Portfolio
From scattered pilots to a focused AI growth engine
Context: A $1B+ device portfolio across three therapeutic areas, with multiple disconnected AI initiatives and limited executive confidence.
- Diagnosis — Mapped 17 AI ideas; only 5 had clear commercial metrics or data readiness.
- Strategy — Prioritized 3 initiatives: predictive account focus, AI‑assisted clinical content, and lead‑to‑rep routing.
- Pilots — Designed 90‑day pilots with control groups, clear endpoints, and governance involvement from day one.
Outcomes (first 6 months)
- 22% lift in marketing‑qualified opportunities in top priority markets
- 18% increase in content engagement from targeted clinical decision‑makers
- Documented framework for AI governance co‑signed by legal, medical, and IT
Why Savi Advisors AI Health
A specialist advisory partner at the intersection of AI, medical devices, and commercial strategy.
We work alongside executive, marketing, and data leaders to create AI programs that withstand internal scrutiny and external regulation.
Medtech‑first expertise
Experience across devices, diagnostics, and digital therapeutics—grounded in clinical, regulatory, and market access realities.
Evidence‑led recommendations
We connect AI ideas to hard numbers: revenue, cost to serve, funnel conversion, and time‑to‑decision metrics.
Pragmatic implementation
We tailor recommendations to your data maturity, tech stack, and field realities—favoring what your teams can actually execute.
Trusted partner to leadership
Executive‑ready materials and narratives that help you align global stakeholders and secure investment for AI growth.
Free AI Growth Consultation
In 30 minutes, we’ll assess where AI can most credibly support growth across your medical device portfolio—and where it shouldn’t be a priority today.
- Review of your current AI initiatives and commercial goals
- Identification of 2–3 high‑leverage AI opportunities
- Suggested next steps tailored to your internal constraints
Designed for marketing, commercial, and strategy leaders at enterprise med‑device organizations. No slide‑ware pitch; working session only.
Request your consultation
Share a few details so we can prepare a relevant discussion for your markets, portfolio, and internal context.
We typically respond within one business day. Your information is kept confidential and is never shared.
Questions from leaders like you
If you prefer, we can address these directly in your consultation and provide examples from comparable med‑device organizations.
Is this relevant if we already have internal AI and data science teams?
Yes. Most of our work is with organizations that have strong internal data capabilities. We focus on where and how AI should be applied to commercial strategy, marketing, and market access—clarifying priorities, defining pilots, and aligning stakeholders—so your internal teams can build the right solutions.
What level of data maturity do we need to benefit from this consultation?
We work across a range of maturities. During the consultation, we will quickly assess your current data landscape and suggest appropriate AI opportunities—for example, where third‑party data, qualitative insights, or lighter‑weight models are more realistic than advanced personalization at scale.
How soon could we see measurable business impact?
Most clients identify at least one high‑potential pilot during the first 30–60 days. Measurable outcomes—such as improved lead quality, better targeting, or streamlined workflows—typically emerge within a 3–6 month window, depending on your decision cycles and internal processes.
Does Savi implement technology, or only advise?
We are an advisory partner first and do not sell software. We help you determine the right initiatives, metrics, and operating models. Implementation is often done by your internal teams or existing technology partners, with Savi providing strategic oversight where helpful.
Savi Advisors AI Health
Advising enterprise medical device organizations on AI‑driven growth, marketing, and commercial strategy with a disciplined, data‑first approach.
Looking to brief your executive team on AI in medtech?